1. Home
  2. BIRK vs GKOS Comparison

BIRK vs GKOS Comparison

Compare BIRK & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRK
  • GKOS
  • Stock Information
  • Founded
  • BIRK 1774
  • GKOS 1998
  • Country
  • BIRK United Kingdom
  • GKOS United States
  • Employees
  • BIRK N/A
  • GKOS N/A
  • Industry
  • BIRK
  • GKOS Medical/Dental Instruments
  • Sector
  • BIRK
  • GKOS Health Care
  • Exchange
  • BIRK Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • BIRK 10.1B
  • GKOS 8.4B
  • IPO Year
  • BIRK 2023
  • GKOS 2015
  • Fundamental
  • Price
  • BIRK $47.24
  • GKOS $100.12
  • Analyst Decision
  • BIRK Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • BIRK 14
  • GKOS 13
  • Target Price
  • BIRK $67.71
  • GKOS $161.54
  • AVG Volume (30 Days)
  • BIRK 1.7M
  • GKOS 952.5K
  • Earning Date
  • BIRK 02-20-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • BIRK N/A
  • GKOS N/A
  • EPS Growth
  • BIRK 179.66
  • GKOS N/A
  • EPS
  • BIRK 1.21
  • GKOS N/A
  • Revenue
  • BIRK $1,929,273,217.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • BIRK $20.85
  • GKOS $27.84
  • Revenue Next Year
  • BIRK $17.06
  • GKOS $27.99
  • P/E Ratio
  • BIRK $38.95
  • GKOS N/A
  • Revenue Growth
  • BIRK 20.51
  • GKOS 21.85
  • 52 Week Low
  • BIRK $41.00
  • GKOS $89.94
  • 52 Week High
  • BIRK $64.78
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • BIRK 48.73
  • GKOS 38.43
  • Support Level
  • BIRK $44.44
  • GKOS $98.03
  • Resistance Level
  • BIRK $47.88
  • GKOS $108.62
  • Average True Range (ATR)
  • BIRK 1.81
  • GKOS 3.94
  • MACD
  • BIRK 0.53
  • GKOS 1.28
  • Stochastic Oscillator
  • BIRK 88.73
  • GKOS 41.26

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: